<<

Conference August 11–13

Pre-Conference Courses August 10–11

JW Indianapolis Marriott 10 S. West Street Indianapolis, IN 46204

REGISTER AT: .org/fallclu

Follow us!

facebook.com/nationallipid

twitter.com/nationallipid

This activity is sponsored by the instagram.com/nationallipid

linkedin.com/national-lipid-association Join Us! PRE-CONFERENCE COURSES

Indianapolis Lipid Academy Thursday, August 10 August 11–13, 2017 Friday, August 11

$550 NLA Members, $950 Non-Members, $0 Trainees We invite you to attend the Fall Clinical Lipid Update (CLU) taking Attend the Lipid Academy, perfect for first-time attendees of the CLU. place August 11–13, 2017 at the JW • In-Depth Indoctrination to Lipid Science Marriott Indianapolis. • Development of Core Competencies in Diagnoses and Treatment of • Interactive Course Design Earn up to 30+ hours of continuing medical education when attending the Masters in Lipidology CLU, additional courses, and symposia. Thursday, August 10 Meet the experts in clinical lipidology, Friday, August 11 network with colleagues, and learn $750 NLA Members, $1,250 Non-Members, $395 Trainees about the latest developments in the field. Hear the latest on what to expect Register for the Masters in Lipidology course today. The new case-based, interactive agenda will improve your with PCSK9 inhibitors, the treatment clinical decision-making skills and help prepare you for of familial chylomicronemia syndrome, certification in clinical lipidology. • Intensive 2-Day Training Course LDL and Lp(a) measurement, and much • In-Depth Review of the Core Curriculum in Clinical more! Lipidology • Ideal for the Advanced-Level Practitioner

We look forward to seeing you in Indy!

1 Register early and save at lipid.org/fallclu Table of Contents Featured Faculty...... 2 Before You Go...... 3 Schedule-at-a-Glance...... 4 Agenda...... 5 Program Planners...... 7 Faculty...... 8 Venue Info...... 9 Special Events...... 10 Accreditation...... 11 Pre-Conference Courses...... 12 Program Overview...... 13 Registration...... 14

Featured Faculty Get Ready to Get Down... FRIDAY • AUGUST 11 • 4:00–4:30 pm AMY C. STURM, MS, CGC, LGC with Dr. Alan Brown’s Band, This End Up When Should I Order Genetic Testing? The Current State and Value of Genetic Testing for FH

SATURDAY • AUGUST 12 • 8:30–9:00 am PETER W.F. WILSON, MD, FNLA PCSK9 and Other New Medications for Lipid Lowering

SATURDAY • AUGUST 12 • 4:05–4:35 pm SERGIO FAZIO, MD, PhD, FNLA Lp(a) Measurement Issues–What is High Lp(a), Which Measurements Do We Use?

SATURDAY • AUGUST 12 • 4:35–5:05 pm JOHN R. GUYTON, MD, FNLA* A Foundation Event not to be missed! LDL Measurements and How They Can be Confounded by August 12, 2017 | 7:00–9:00 pm | $70/person Lp(a) and Low LDL JW Marriott * Diplomate, American Board of Clinical Lipidology

Register early and save at lipid.org/fallclu 2 Before You Go

NLA Members Save Up to $400 Download the App* Not yet a member? Join the National Lipid Association today and save up to $400 on your Customizable registration, when registering before June 9, 2017, Calendar or $350 when registering after the early bird rate ends. Learn more about NLA membership by visiting lipid.org/join.

NLA’s Trainee Travel Grant Program Are you a trainee who has a focus in lipid management? Learn about the NLA’s trainee travel grant program! Fifteen grants are available for the NLA Lipid Academy course, each including a $500 travel grant and complimentary attendance to the Lipid Academy course — plus NLA membership for Agenda Exhibit Hall lipid-focused trainees is always complimentary. Due to the popularity of the program, please act quickly and contact Amanda East at [email protected] for *Attendees will more information. Visit lipid.org/education/fellows receive an email for additional trainee opportunities. when the app is ready to download. Subscribe to our Get Engaged email list at Be part of the conversation and stay in the know by lipid.org/subscribe following the NLA on Twitter, Instagram, Facebook, to receive the email. and LinkedIn. Use hashtag #NLAIndy when posting about the meeting. Questions about how to use social media? Read our five-minute-guide here: lipid.org/social.

3 Register early and save at lipid.org/fallclu Schedule-at-a-Glance “The best professional meeting I have ever attended in 15 years of practice.” Thursday, August 10 Friday, August 11 Saturday, August 12 Sunday, August 13 — Anita Airee, DPH Masters in Lipidology CLU Registration CLU Registration CLU Registration Registration 12:30–6:00 pm 7:00 am–6:00 pm 7:00–11:15 am 7:30–8:00 am Breakfast “The NLA conferences remain the Lipid Academy 7:00–7:50 am best opportunity for lipid specialist and Registration other physicians to seriously explore the GENERAL 8:00–8:30 am challenges and opportunities for preventing Masters in Lipidology Masters in Lipidology Session II Session VI atherosclerotic events in our patients.” 8:00 am–6:00 pm 7:30 am–3:30 pm 7:50–10:00 am 8:00–9:20 am — Jeffrey Siegel, MD Lipid Academy Lipid Academy Session III Session VII 8:35 am–5:15 pm 8:00 am–3:00 pm 10:20 am–12:25 pm 9:20–11:15 am “The most concentrated amount Session I Session IV of useful information regarding 3:45–6:00 pm 1:40–3:15 pm management of lipid and Mini Session disorders of any meeting I have

EDUCATION 3:25–4:00 pm attended in recent years.” — Marshall Elam, MD Session V 4:00–6:00 pm Welcome Reception in Exhibit Hall Hours “The courses and topic discussed Exhibit Hall 7:00 am–3:00 pm at NLA are very cutting edge 6:00–7:00 pm Breakfast and extremely helpful in managing 7:00–7:50 am day-to-day patients with lipid

HALL abnormalities. The speakers are EXHIBIT Lunch some of the BEST in the Country!” 12:40–1:40 pm — Munni Selagamsetty, MD MWLA/SELA News & Notes 12:25–12:40 pm “I love coming to NLA meetings. New Member Lunch I know I am with national and 12:40–1:40 pm international thought leaders regarding the subject of and prevention EVENTS

SPECIAL Foundation of the NLA Event and treatment of vascular disease.” 7:00–9:00 pm — Vanessa Norton, ARNP, MSN

4 Register early and save at lipid.org/fallclu Agenda

FRIDAY, AUGUST 11 3:45–3:55 pm Chapter Presidents Welcome & Introduction Session I: The Value and Impact of Genetic Testing for FH: From Genetic Counselor to Patient and Back Again 3:55–4:00 pm ARS Questions 4:00–4:30 pm Getting Personal: A Cardiovascular Genetic Counselor and His Diagnosis of FH Ben Helm, MS, CGC, LGC 4:30–5:00 pm When Should I Order Genetic Testing? The Current State and Value of Genetic Testing for FH Amy C. Sturm, MS, CGC, LGC A GenomeFIRST Approach to FH: Lessons Learned from Large Scale Sequencing Efforts and FH Return of 5:00–5:30 pm Results Michael F. Murray, MD 5:30–6:00 pm ARS Questions and Q&A Panel 6:00–7:00 pm Welcome Reception in Exhibit Hall SATURDAY, AUGUST 12 7:00–7:50 am Breakfast in Exhibit Hall 7:50–8:00 am Housekeeping Notes & ARS Questions Session II: PCSK9 Inhibitors- What Can Lipidologists Expect for the Future? 8:00–8:30 am Debate–PCSK9 Inhibitors in Primary Prevention, Yes or No? 8:00–8:10 am Yes John R. Guyton, MD, FNLA* 8:10–8:20 am No Sergio Fazio, MD, PhD, FNLA* 8:20–8:30 am Rebuttal–5 Minutes Each

8:30–9:00 am PCSK9 and Other New Medications for Lipid Lowering Peter W.F. Wilson, MD, FNLA*

9:00–9:30 am New Technologies in Development Targeting PCSK9–What’s on the Horizon? Dave Dixon, PharmD, BCPS, CDE, CLS, FNLA 9:30–10:00 am ARS Questions and Q&A Panel 10:00–10:20 am Break in Exhibit Hall Session III: Chylomicronemia Syndrome 10:20–10:25 am ARS Questions Alen S. Brown, MD, FNLA* 10:25–10:55 am The Challenges of Treating Chylomicronemia Across the Life Span Ann Liebeskind, MD* 10:55–11:25 am Dietary Restrictions for Chylomicronemia Syndrome Lori A. Alexander, MSHS, RD, CCRC, CLS, FNLA Katherine S. Rhodes, PhD, RD 11:25–11:55 am Complex Cases for Chylomicronemia Syndrome Lauren Williams, MCN, RD, LD 11:55 am–12:25 pm ARS Questions and Q&A Panel 12:25–12:40 pm MWLA/SELA News & Notes 12:40–1:40 pm Lunch in Exhibit Hall Session IV: Now You See It, Now You Don’t: Great Debates on the Role of Calcium Scoring in Clinical Decision Making in Dyslipidemia 1:40–1:45 pm ARS Questions 5 Register early and save at lipid.org/fallclu 1:45–1:50 pm What is the True “Power of Zero”? Kellie H. McLain, ANP-C, CLS Pro–Khurram Nasir, MD, PhD 1:50–2:10 pm Debate Con–Salim S. Virani, MD, PhD 2:10–2:20 pm Rebuttal–5 Minutes Each 2:20–2:25 pm When is “Enough Really Enough”? Kellie H. McLain, ANP-C, CLS Pro–Khurram Nasir, MD, PhD 2:25–2:45 pm Debate Con–Salim S. Virani, MD, PhD 2:45–2:55 pm Rebuttal–5 Minutes Each 2:55–3:15 pm ARS Questions and Q&A Panel 3:15–3:25 pm Break Mini Session 3:25–3:30 pm ARS Questions 3:30–4:00 pm and CVD Kaye-Eileen Willard, MD, FNLA* Session V: LDL and Lp(a) Measurement Potential Pitfalls and Problems 4:00–4:05 pm ARS Questions 4:05–4:35 pm Lp(a) Measurement Issues–What is High Lp(a), Which Measurements Do We Use? Sergio Fazio, MD, PhD, FNLA* 4:35–5:05 pm LDL Measurements and How They Can be Confounded by Lp(a) and Low LDL John R. Guyton, MD, FNLA* 5:05–5:35 pm Practical Approaches from a Clinical Standpoint–What to Do About Lp(a) Alan S. Brown, MD, FNLA* 5:35–6:00 pm ARS Questions and Q&A Panel Foundation of the NLA Event SUNDAY,7:00–9:00 pmAUGUST 13Get Down with Alan Brown and This End Up Session VI: Coffee and Cases

7:00–7:50 am Breakfast

7:50–8:00 am Housekeeping Notes & ARS Questions

Patient Present with: Moderator: Pamela B. Morris, MD, FNLA* Chronic Kidney Disease in Stage 4 & 5 and the Use of Therapy Panelists: 8:00–9:00 am Peter W.F. Wilson, MD, FNLA* “My Legs Hurt!” A Case of Statin Related Myalgias In the Setting of Peripheral Vascular Disease Susan Halli Demeter, RN, DNP, CFNP, CLS Achy-Breaky: A Patient with Gout and CHD, Treated with Colchicine Mary Katherine Cheeley, PharmD, BCPS, CLS

9:00–9:20 am ARS Questions and Q&A Panel Session VII: Statin Related Muscle Necrosis

9:20–9:25 am ARS Questions

9:25–10:05 am Statin-Associated Myopathy Beth Taylor, PhD

10:05–10:45 am Management of Statin-Induced Myositis Steven Baker, MD, MSc

10:45 am Adjourn

* Diplomate, American Board of Clinical Lipidology The faculty and schedule are subject to change. 6 Register early and save at lipid.org/fallclu Program Planners

Anne C. Goldberg, MD, FACP, FNLA* James A. Underberg, MD, MS, FNLA* Committee Co-Chair Committee Co-Chair President, Foundation of the NLA President, National Lipid Association Professor of Medicine Clinical Assistant Professor of Medicine Washington University School of Medicine NYU School of Medicine & NYU Center for Prevention of St. Louis, MO Director, Bellevue Hospital Lipid Clinic Sanford A. Carimi, MD, FNLA* New York, NY President, MWLA Director, UnityPoint-Meriter Lipid Clinic Carol Kirkpatrick, PhD, RDN, MPH, CLS, FNLA Monona, WI Wellness Center Director Clinical Assistant Professor Deborah S. Croy, DNP, ANP, CLS, FNLA Idaho State University President, SELA Pocatello, ID Nurse Practitioner Bland County Medical Clinic Pamela B. Morris, MD, FNLA* Bastian, VA Director, Preventive Cardiology Co-Director, Women’s Heart Care Ira J. Goldberg, MD, FNLA Medical University of South Carolina Clarissa and Edgar Bronfman, Jr. Professor Mt. Pleasant, SC Director, Division of Endocrinology, Diabetes & NYU Langone Medical Center Joseph J. Saseen, PharmD, CLS, FNLA New York, NY Professor Clinical Pharmacy & Family Medicine Vanessa L. Hurta, NP, MS, CLS University of Colorado Denver Bellevue Hospital Center Lipid Clinic Anschutz Medical Campus New York, NY Aurora, CO

Daniel E. Soffer, MD, FNLA* Elizabeth Jackson MSN, ACNS-BC, CLS, FNLA University of Pennsylvania Health System Cardio Texas Internal Medicine/Clinical Lipidology St. David’s Medical Center Perelman Center for Advanced Medicine Austin, TX Philadelphia, PA

Peter H. Jones, MD, FNLA* Nathan O. Stitziel, MD, PhD Chief Science Officer, National Lipid Association Assistant Professor of Medicine & Associate Professor of Medicine Washington University School of Medicine Co-Director Saint Louis, MO & Atherosclerosis Clinic Center for Cardiovascular Disease Prevention Houston Methodist DeBakey Heart & Vascular Center * Diplomate, American Board of Clinical Lipidology Baylor College of Medicine Houston, TX The NLA invites speakers and guests to provide scientific medical opinion, which do not necessarily reflect the policy of the NLA. The schedule and faculty are subject to change.

7 Register early and save at lipid.org/fallclu Fa c u lty

Lori Alexander, MSHS, RD, CCRC, CLS, FNLA John R. Guyton, MD, FNLA* Amy C. Sturm, MS, CGC, LGC Site Manager Professor of Medicine Associate Professor, Internal Medicine St. Johns Center for Clinical Research Assistant Professor of Wexner Medical Center at The Ohio State Ponte Vedra, FL Department of Medicine University Duke University School of Medicine Division of Human Genetics Steven Baker, MD, MSc Durham, NC Columbus, OH Associate Professor, Division of Physical Medicine & Rehabilitation Susan Halli Demeter, RN, DNP, CFNP, CLS Beth Taylor, PhD Department of Medicine Faculty Associate Associate Professor of Kinesiology Research Director, Division of Physical Medicine & DNP Program Unioversity of Conneticut Rehabilitation Arizona State University Storrs, CT Hamilton Hospitals Assessment Center Phoenix, AZ Director of Exercise Research Endowed Professorship in Neuromuscular Diseases Hartford Hospital McMaster University Benjamin M. Helm, MS, CGC, LGC Hartford, CT Hamilton, Ontario, Canada Indiana University School of Medicine Salim S. Virani, MD, PhD Alan S. Brown, MD, FNLA* Indianapolis, IN Assistant Professor Director, Division of Cardiology Medicine-Atherosclerosis & Lipidology Advocate Lutheran General Hospital Ann Liebeskind, MD* Assistant Professor Co-Director, Cardiology Service Line Founder, Complex Lipids Clinic Medicine-Cardiology Advocate Medical Group Mobile Health Team Baylor College of Medicine Clinical Associate Professor Neenah & Wauwautosa, WI Houston, TX Loyola Stritch School of Medicine Park Ridge, IL Kellie H. McLain, ANP-BC, CLS Kaye-Eileen Willard, MD, FNLA* Medical University of South Carolina Chief of Department of Medicine Mary Katherine Cheeley, PharmD, BCPS, CLS Mt. Pleasant, SC Medical Director, Chronic Disease Management Clinical Pharmacist Wheaton Franciscan Healthcare, All Saints Grady Health System Racine, WI Atlanta, GA Michael F. Murray, MD Associate Geneticist, Brigham & Women’s Hospital Peter W.F. Wilson, MD, FNLA* Dave L. Dixon, PharmD, BCPS, CDE, CLS, FNLA Instructor in Medicine, Harvard Medical School Professor of Medicine Associate Professor, Ambulatory Care Brigham & Women’s Hospital Division of Cardiology Vice-Chair of Clinical Services Department of Medicine–Genetics Emory University School of Medicine Department of Pharmacotherapy & Outcomes Boston, MA Professor of Public Health Science Rollins School of Public Health Virginia Commonwealth University Khurram Nasir, MD, PhD Director, & Genomic Medicine School of Pharmacy Research Director, Center for Prevention & Atlanta VA Medical Center Richmond, VA Wellness Atlanta, GA Director, High-Risk Cardiovascular Disease Clinic Sergio Fazio, MD, PhD, FNLA* Baptist Health South Florida Lauren Williams, MCN, RD, LD William & Sonja Connor Chair of Preventive Miami, FL Clinical Dietitian II Cardiology REACH/Endocrinology Clinic Professor of Medicine and Physiology & Katherine S. Rhodes, PhD, RD Cook Children’s Medical Center Director, Center for Preventive Cardiology Services Fort Worth, TX The Knight Cardiovascular Institute of OHSU University of Michigan Cardiovascular Medicine Portland, OR Ann Arbor, MI

* Diplomate, American Board of Clinical Lipidology

8 Register early and save at lipid.org/fallclu Venue Info While in Indianapolis Visit...

JW Marriott Indianapolis Indianapolis Motor Speedway Museum 10 S. West Street indianapolismotorspeedway.com/at-the-track/museum Indianapolis, IN 46204 The Indianapolis Motor Speedway has been around since 1909, so this epic track has seen more than 100 races speed by. The 30,000-square-foot museum came about 50 years afterward, featuring about 75 cars and Meeting Room Rate: $189/night ++ even a theater that shows Indy 500 footage throughout the years. Visitors Room Reservation Cut-Off-Date: July 19, 2017 have the choice to see the complex by purchasing race tickets, visiting the For reservations call (866) 704-6162 and ask for the museum or taking the very popular (and comprehensive) grounds tour. National Lipid Association room block. The Central Canal Recently named as the 25th best hotel in the visitindy.com/indianapolis-canal-walk The Central Canal, which also goes by the name Indy Canal Walk, was born world and number one in the Midwest by Conde in the 1840s when the Indiana state government was trying to bring more Nast, JW Indy is one of five Marriott Place hotels commerce to the city. But soon after, the state found itself bankrupt and in downtown Indianapolis. They are also home the plans for a 296-mile waterway were shelved. Today, the Central Canal to Indy’s best Italian restaurant by Thrillist.com, is a 3-mile loop that flows by the Indiana State Museum, Victory Field, the Osteria Pronto. In addition, their enclosed skywalk Indianapolis Zoo and the 250-acre White River State Park, among other system provides business and leisure travelers easy popular attractions. You can walk alongside the canal or book a segway tour, but you can also hire a gondolier or rent a pedal boat or kayak. access to top area attractions. Indianapolis Museum of Art imamuseum.org Spread out across 152 acres and featuring more than 54,000 works of art spanning 5,000 years, the Indianapolis Museum of Art is an impressive institution. It’s also among the 10 largest art museums in the U.S. Superla- tives aside, what visitors love most about IMA is its variety. Not only does it offer Neoimpressionist paintings (like Georges Seurat), contemporary art and Chinese ceramics, but it also boasts one of the largest contempo- rary art parks in the U.S. — The Virginia B. Fairbanks Art & Nature Park: 100 Acres.

Indiana War Memorial indianawarmemorials.org Considered an Indiana landmark, the Indiana War Memorial comprises two museums, three parks and 24 acres of monuments, statues, sculp- tures and fountains. So, if you’re a fan of the National Mall in Washington, D.C., you’ll likely enjoy spending a few hours here. In fact, Indianapolis is second only to D.C. in acreage and number of monuments dedicated to veterans. 9 Register early and save at lipid.org/fallclu Special Events Welcome Reception Friday, August 11 Foundation Event: Get Down with 6:00–7:00 pm Dr. Alan Brown’s Band, This End Up Saturday, August 12, 2017 Join your colleagues and the 7:00–9:00 pm exhibitors for an opening reception $70/person on Friday evening in the exhibit hall. Visit with more than 20 Join us onsite at the JW Marriott for an evening packed with music, food, and exhibiting companies and mingle, fun. Support the Foundation of the National Lipid Association (FNLA), while while enjoying tasty hors d’oeuvres enjoying today’s most popular songs, delicious apps, and tasty drinks with and cocktails. colleagues and friends. FNLA board member Dr. Alan Brown and his band, This End Up, will provide the tunes for the evening! After a full day of sessions, This reception is included in the registration; guests with a guest pass are what better way to unwind! also welcome.

Separate registration is requited for this event. See registration page to purchase tickets. New Member Lunch Saturday, August 12 12:40–1:40 pm

Did you join the NLA within the last year? Is this your first NLA Clinical Lipid Update? Attend the New Member Luncheon on Saturday to meet new members and chapter leaders, as well as national leader- ship. Here you can learn how the NLA can benefit your career and see where your expertise can be added to the many different areas of the NLA. It is a wonderful opportunity to ask leaders questions you may have about their experience in the association and how they have benefited from the educational opportunities and the relationships created. Come enjoy a great lunch and network with other members and leaders that will enrich your experience as an NLA member!

10 Register early and save at lipid.org/fallclu Pharmacists Accreditation Day 1 Morning Session - Universal Activity Number - 0624-0000-17-013-L01-P (Knowledge) This Activity has been approved for 3.25 contact hour(s) (.325 CEUs) of the Accreditation Council for Pharmacy Education. Day 1 Afternoon Session - Universal Activity Number - 0624-0000-17-014-L01-P (Knowledge) Fall Clinical Lipid Update This Activity has been approved for 4.25 contact hour(s) (.425 CEUs) of the Accreditation Council for Pharmacy Education. Day 2 Morning Session - Universal Activity Number - 0624-0000-17-015-L01-P (Knowledge) In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National This Activity has been approved for 4.00 contact hour(s) (.40 CEUs) of the Accreditation Council for Pharmacy Education. Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Day 2 Afternoon Session - Universal Activity Number - 0624-0000-17-016-L01-P (Application) Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the This Activity has been approved for 2.25 contact hour(s) (.225 CEUs) of the Accreditation Council for Pharmacy Education. healthcare team. Nursing Physician Credit Designation Statement The maximum number of hours awarded for this CE activity is 13.5 contact hours. The National Lipid Association designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only credit Day 1 Morning Session–3.1 credits; Day 1 Afternoon Session–4.2 credits; Day 2 Morning Session–4 credits; Day 2 Afternoon Session–2.2 credits. commensurate with the extent of their participation in this activity. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Physician Assistants NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. Masters in Lipidology Course In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Dietitians Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 14 continuing professional education units (CPEUs) for completion of this the healthcare team. program/materials. CDR Accredited Provider #NL002. Physician Credit Designation Statement Pharmacists The National Lipid Association designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credits™. Physicians should claim only credit Session I–Universal Activity Number 0624-0000-17-033-L01-P (Knowledge) commensurate with the extent of their participation in the activity. This Activity has been approved for 2.25 contact hour(s) (.225 CEUs) of the Accreditation Council for Pharmacy Education Physician Assistants Session II–Universal Activity Number 0624-0000-17-034-L01-P (Knowledge) NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME. This Activity has been approved for 2.25 contact hour(s) (.225 CEUs) of the Accreditation Council for Pharmacy Education Dietitians Session III–Universal Activity Number 0624-0000-17-035-L01-P (Knowledge) The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). This Activity has been approved for 2.25 contact hour(s) (.225 CEUs) of the Accreditation Council for Pharmacy Education Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 16 continuing professional education units (CPEUs) for completion of this program/materials. CDR Accredited Provider #NL002. Session IV–Universal Activity Number 0624-0000-17-036-L01-P (Knowledge) This Activity has been approved for 1.75 contact hour(s) (.175 CEUs) of the Accreditation Council for Pharmacy Education Pharmacists Day 1 Morning Session – Universal Activity Number - 0624-0000-17-017-L01-P (Knowledge) Mini Session–Universal Activity Number 0624-0000-17-037-L01-P (Knowledge) This Activity has been approved for 4.00 contact hour(s) (.40 CEUs) of the Accreditation Council for Pharmacy Education. This Activity has been approved for .75 contact hour(s) (.075 CEUs) of the Accreditation Council for Pharmacy Education Day 1 Afternoon Session – Universal Activity Number - 0624-0000-17-018-L01-P (Knowledge) This Activity has been approved for 4.50 contact hour(s) (.450 CEUs) of the Accreditation Council for Pharmacy Education. Session V–Universal Activity Number 0624-0000-17-038-L01-P (Knowledge) Day 2 Morning Session – Universal Activity Number - 0624-0000-17-019-L01-P (Knowledge) This Activity has been approved for 2.00 contact hour(s) (.20 CEUs) of the Accreditation Council for Pharmacy Education This Activity has been approved for 5.00 contact hour(s) (.50 CEUs) of the Accreditation Council for Pharmacy Education. Day 2 Afternoon Session – Universal Activity Number - 0624-0000-17-020-L01-P (Application) Session VI–Universal Activity Number 0624-0000-17-039-L01-P (Application) This Activity has been approved for 2.25 contact hour(s) (.225 CEUs) of the Accreditation Council for Pharmacy Education. This Activity has been approved for 1.50 contact hour(s) (.150 CEUs) of the Accreditation Council for Pharmacy Education Nursing Session VII–Universal Activity Number 0624-0000-17-040-L01-P (Knowledge) The maximum number of hours awarded for this CE activity is 15.6 contact hours. This Activity has been approved for 2.00 contact hour(s) (.20 CEUs) of the Accreditation Council for Pharmacy Education Day 1 Morning Session–4.0 credits; Day 1 Afternoon Session–4.5 credits; Day 2 Morning Session–4.9 credits; Day 2 Afternoon Session–2.2 credits. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined. Nursing The maximum number of hours awarded for this CE activity is 13.9 contact hours. Session I–2.1 credits; Session II–2.2 credits; Session III–2.1 credits; Session IV–1.6 credits; Mini Session–.6 credits; Session V–2.0 credits; Session VI–1.8 credits; Session VII–2.9 credits. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Lipid Academy Criteria for Success: In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Statements of credit will be awarded based on the participant´s attendance and submission of the activity evaluation form. A statement of credit Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme. Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the For Pharmacists: Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service healthcare team. within 4 weeks.

Physician Credit Designation Statement Disclosure Statement: The National Lipid Association designates this live activity for a maximum of 13.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The commensurate with the extent of their participation in the activity. faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation Physician Assistants of the activity. NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME. Commercial Support: Dietitians Full notification of commercial support will be provided in the mobile app. The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 13 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

11 Register early and save at lipid.org/fallclu Register early and save at lipid.org/springclu NLA Lipid Academy Masters in Lipidology Course Pre-Conference Workshop Pre-Conference Workshop Thursday, August 10 • 8:35 am–5:15 pm Thursday, August 10 • 8:00 am–6:00 pm Friday, August 11 • 8:00 am–3:00 pm Friday, August 11 • 7:30 am–3:30 pm $550 NLA Members, $950 Non-Members, $0 Trainees $750 NLA Members, $1,250 Non-Members, $395 Trainees

Overview Overview The NLA’s Lipid Academy provides a comprehensive, in-depth indoctrination to lipid science and is open to all health care professionals interested in This intensive 2-day training course offers an in-depth review of the core curriculum in Clinical Lipidology for healthcare professionals who desire to developing a core competency in the diagnosis and treatment of dyslipidemia. The interactive Lipid Academy course provides health professionals with practice at an advanced level within the field. The new case-based, interactive agenda will improve your clinical decision making skills and help prepare the knowledge and tools necessary to work effectively in a lipid practice, and will serve as a preparatory course for the Annual Scientific Session and other you for certification by the American Board of Clinical Lipidology (ABCL) or the Accreditation Council in Clinical Lipidology (ACCL). For those not preparing advanced lipid training. Additionally, participants earn NLA endorsed lipid education credits that will help to fulfill the CME requirements necessary to be for certification, the course provides an excellent update and refresher on core concepts in Lipidology. Learn from leading experts, assess your eligible for the Clinical Lipidologist physician certifying examination, the Clinical Lipid Specialist (CLS) Certification examination or the Lipid Competency knowledge of lipid science and advance your personal standard of practice. Certificate (LCC) exam offered by the Accreditation Council for Clinical Lipidology (ACCL). Target Audience The Lipid Academy is offered as a 2-day course prior to each scientific meeting conducted by the NLA. This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, advanced practice registered nurses, nurse practitioners and registered dietitians with an interest in lipid management. Target Audience This activity is designed to meet the needs of physicians, physician assistants, pharmacists, advance practice registered nurses, registered nurses, nurse Type of Activity practitioners and registered dietitians with an interest in lipid management. Application, Knowledge

Type of Activity Learning Objectives: Application, Knowledge At the conclusion of this activity, participants should be able to: • Explain lipoprotein metabolism and its role in the pathogenesis of atherosclerosis Learning Objectives • Describe genetic disorders affecting lipoprotein metabolism At the conclusion of this activity, participants should be able to: • Describe the vascular and pathophysiology of atherosclerosis • Describe the functions and sources of and including the role of in atherosclerosis • Apply basic principles of evidence based medicine to enhance understanding of clinical trial results, methods for cardiovascular risk • Explain the pathogenesis of atherosclerosis stratification, and applying new research into practice • Identify the role of inflammation in atherogenesis • Explain clinical practice guidelines, the different types of evidence used to make clinical guidelines, and the role of clinical judgment in applying • Discuss clinical trials including their role in lipid and lipoprotein treatment in cardiovascular prevention guidelines to practice • Review the clinical trials of lipid-altering drug therapies used in cardiovascular disease (CVD) prevention • Outline current issues and approaches to global cardiovascular risk assessment • Apply basic principles of statistics to enhance understanding of clinical trials related to lipid management • Assess traditional and emerging biomarkers for the prevention and treatment of atherosclerotic cardiovascular disease • Compare and contrast the effectiveness of available risk assessment instruments and markers in predicting cardiovascular risk in all • Review the role of subclinical atherosclerosis testing (imaging) in cardiovascular disease risk assessment and management groups • Identify the evidence base that supports current dietary recommendations for heart health • Identify primary and secondary causes of dyslipidemia • Describe effective diet and lifestyle (exercise, weight management) strategies for the management of dyslipidemia and cardiovascular risk • Recognize the role of drug therapy in the management of dyslipidemia • Identify how general dietary patterns and specific macronutrients (, ) affect coronary heart disease and lipids • Review the mechanism of action, pharmacokinetics, and efficacy of available FDA approved drugs for the management of lipid disorders • Explain how obesity and adiposopathy contribute to the metabolic syndrome and diabetes mellitus • Assess the side effects of lipid-altering drugs to encourage their safe use in cardiovascular disease prevention • Identify management strategies for the cardiometabolic risk factors of the metabolic syndrome • Describe the appropriate use of lipid-altering drugs in special • Review the mechanism of action, pharmacokinetics, and efficacy of approved drugs for the management of lipid disorders • Describe effective diet and lifestyle strategies for long-term obesity and dyslipidemia management • Assess the side effects of lipid-altering drugs to encourage their safe use in cardiovascular disease prevention • Describe the association of specific dietary patterns such as increased sodium and sugar intake, and the increased risk for cardiovascular disease • Review clinical trials of lipid-altering drug therapies used in cardiovascular disease prevention associated morbidity and mortality • Describe combination therapies for the management of complex lipid disorders and residual risk • Compose a clinical care plan for reducing risk of CVD in patients with dyslipidemia • Manage complex dyslipidemia and dyslipidemia in special populations • Analyze case studies in lipid management to improve treatment and prevention of cardiovascular disease • Discuss strategies to improve the knowledge, skills, or performance of the healthcare team • Analyze lipid cases for health professionals seeing patients with complex disorders • Identify the management of dyslipidemia in special populations based on gender, culture, and disease variables • Outline current guidelines on the management and treatment of patients with dyslipidemia • Discuss strategies to improve the knowledge, skills or performance of the healthcare team Course Faculty Course Faculty Lori Alexander, MSHS, RD, CCRC, CLS, FNLA Joseph J. Saseen, PharmD, CLS, FNLA Harold E. Bays, MD, FNLA* Terry A. Jacobson, MD, FNLA* Site Manager Professor Medical Director/President Professor of Medicine St. Johns Center for Clinical Research Clinical Pharmacy & Family Medicine Louisville Metabolic and Atherosclerosis Director, Office of Health Promotion & Disease Ponte Vedra, FL University of Colorado Denver Research Center Prevention Anschutz Medical Campus Louisville, KY Emory University Ann Liebeskind, MD* Aurora, CO Atlanta, GA Founder, Complex Lipids Clinic Alan S. Brown, MD, FNLA* Mobile Health Team Daniel E. Soffer, MD, FNLA* Director, Division of Cardiology Kevin C. Maki, PhD, CLS, FNLA Neenah & Wauwautosa, WI University of Pennsylvania Health System Advocate Lutheran General Hospital Chief Science Officer Internal Medicine/Clinical Lipidology Co-Director, Cardiology Service Line Midwest Center for Metabolic & Cardiovascular Pamela B. Morris, MD, FNLA* Perelman Center for Advanced Medicine Advocate Medical Group Research Director, Preventive Cardiology Philadelphia, PA Clinical Associate Professor Chicago, IL Co-Director, Women’s Heart Care Loyola Stritch School of Medicine Medical University of South Carolina Park Ridge, IL Carl E. Orringer, MD, FNLA* Mt. Pleasant, SC Associate Professor of Medicine Anne C. Goldberg, MD, FACP, FNLA* University of Miami Professor of Medicine School of Medicine Washington University School of Medicine Miami, FL St. Louis, MO *Denotes Diplomate, American Board of Clinical Lipidology *Denotes Diplomate, American Board of Clinical Lipidology (ABCL) (ABCL) Faculty subject to change Faculty subject to change 12 Register early and save at lipid.org/fallclu Register early and save at lipid.org/springclu Program Overview

Registration Hours Session III: Chylomicronemia Syndrome Friday, August 11 | 12:30–6:00 pm • Describe the prevalence, risk, and complications of chylomicronemia Saturday, August 12 | 7:00 am–6:00 pm syndrome; Sunday, August 13 | 7:00–11:15 am • Assess the impact of diet in the management of chylomicronemia; $545 NLA Members, $895 Non-members, $75 Trainees • Analyze complex cases for health professionals seeing patients with chylomicronemia syndrome; Target Audience Session IV: Now You See It, Now You Don’t: Great Debates on the Role of This activity is designed to meet the needs of physicians, physician assistants, Calcium Scoring in Clinical Decision Making in Dyslipidemia pharmacists, registered nurses, nurse practitioners, advance practice registered • Compare and contrast appropriate treatment options for patients based on nurses, and registered dietitians with an interest in lipid management. calcium scoring; Mini Session Type of Activity • Discuss the association between the gut microbiome and its possible Live Activity influence on the development of CVD; Knowledge Session V: LDL and Lp(a) Measurement Potential Pitfalls and Problems • Explore the developing measures that will guide the diagnosis and treatment Educational Objectives of lipid disorders in the future; At the conclusion of this activity, all participants should be able to: • Describe treatment options for patients with high Lp(a); • Discuss strategies to improve the knowledge, skills or performance of the Session VI: Coffee and Cases healthcare team; • Analyze lipid cases for health professionals seeing patients with complex Session I: The Value and Impact of Genetic Testing for FH: From Genetic disorders; Counselor to Patient and Back Again • Implement strategies for the entire patient care team to manage complex • Explain the benefits of genetic testing in Familial Hypercholesterolemia (FH) cases; screening; Session VII: Statin-Related Muscle Necrosis • Recognize the importance of in the identification of patients with • Implement appropriate assessment and management techniques for muscle- FH; related adverse events associated with lipid-altering drugs. • Discuss the role of genetic counseling in FH; Session II: PCSK9 Inhibitors – What Can Lipidologists Expect for the Future? • Interpret important recent clinical trial research and its impact on daily clinical practice; • Assess the implications of ongoing lipid treatment outcomes trials for the future clinical management of patients with dyslipidemia; • Discuss emerging therapeutic targets for the management of dyslipidemia;

13 Register early and save at lipid.org/fallclu 2017 Fall Clinical Lipid Update • August 11–13, 2017 • JW Marriott Indianapolis

1 First Name Middle Initial Last Name Guest name(s), if attending meeting:

Mailing Address

Membership status: City State or Province Zip Country I am currently a member. My application for membership has Phone Emergency Contact/Phone Phone been submitted and confirmed. I will apply at lipid.org. Email Please send me membership information. Check all that apply: MD/DO/PhD RN NP PA RPH PharmD RD Other ______

Circle fee based on NLA Member NLA Member Non-Member Trainee Registration: Registration and payment must be received no later than July 11, 2017. attendee type Early Bird Rate Discounted Rate Rate Rate† After this date, meeting materials and name badge cannot be guaranteed. Before 6/9/17 After 6/9/17 By registering for the 2017 NLA Fall Clinical Lipid Update, attendee understands and agrees that attendee’s name, city, and state may be shared with other attendees and exhibitors. By allowing Clinical Lipid Update $495 $545 $895 $75 an exhibitor to scan the conference badge, attendee understands, agrees, and consents to the sharing of attendee’s contact information with the company that scanned the conference 2 August 11–13, 2017 badge. Includes one admission badge to Exhibit Hall for all food functions. Cancellation: Telephone cancellations will not be accepted. A written notice of cancellation must be received no later than July 11, 2017. This includes social events and guest fees. There Professional Development will be a $100 fee for all cancellations. There will be no refunds if cancelling within 30 days of the 3 Masters in Lipidology Course* $750 $750 $1250 $395 start of the meeting date. August 10–11, 2017 Special needs: ______Lipid Academy $550 $550 $950 $0 ______August 10–11, 2017 ADA Compliance: Attendees who need additional reasonable accommodations or who have special needs should contact the NLA office at (904) 998-0854. Registration Fee Total $______$______$______$______*Master’s Course: To purchase the NLA-SAPs, please go to: lipid.org/education/nlasap. Special Events and Guest Fees †Trainee Rate: Available for those individuals actively enrolled in a graduate or postgraduate 4 Exhibit Hall Pass-Guest(s) $150 X____ = $______training program for the treatment or investigation of lipid disorders and in pursuit of full Foundation Event: Get Down With This End Up $70 X____ = $______credentialing in their specialized area of medical study. A letter from the program director or the school registrar must accompany your registration. Guest Totals $______Registration Discount Disclaimer: Discount codes cannot be retroactively applied to existing Combined Total Fees $______meeting registrations. The meeting discount codes are applicable to new registrants only.

Payment Method 3 Easy Ways to Register 5 Mail Fax VISA MC AMEX Check Make checks payable to the NLA National Lipid Association NLA at (904) 998-0855 6816 Southpoint Parkway, Suite 1000 Fax with credit card number Credit Card # Exp. Date Jacksonville, FL 32216 and signature Online Signature lipid.org/fallclu Name on Card 14 Register early and save at lipid.org/springclu National Lipid Association 6816 Southpoint Pkwy., Suite 1000 Jacksonville, FL 32216